The Claim
Genetically predicted plasma erythritol levels have no causal relationship with coronary artery disease, type 2 diabetes, or fasting glucose levels.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with naturally higher levels of erythritol in their blood do not develop coronary artery disease, type 2 diabetes, or elevated fasting glucose because of those levels.
See the scientific wording
Mendelian randomization analyses show no causal relationship between genetically predicted plasma erythritol levels and coronary artery disease, type 2 diabetes, or fasting glucose, suggesting that elevated erythritol is a biomarker rather than a driver of cardiometabolic disease.
Erythritol in the blood does not cause heart disease, diabetes, or high blood sugar because it does not alter how the body produces glucose, how insulin works, or how arteries become blocked. Even though it can affect platelets and blood vessels in some ways, these effects do not lead to disease when erythritol levels are naturally high due to genetics.
What the research says
1 studyStudy: Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
People who naturally have more erythritol in their blood don’t get heart disease or diabetes because of it — the study found no proof that erythritol causes these problems, suggesting it’s just a sign, not a cause.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.